Menstruation Flashcards

1
Q

Definition of primary amenorrhea

A
  • absence of spontaneous menstruation by 16yo WITH secondary sex characteristics or 14yo WITHOUT secondary sex characteristics
  • 4 main categories based on karyotype
    • Turner syndrome (Gonadal agenesis) - 45 XO
    • Hypothalamic-pituitary insufficiency - 46 XX
    • Androgen insensitivity - 46 XY
    • Imperforate hymen - 46 XX
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of secondary amenorrhea

A
  • woman who has previously menstruated
  • absence of menses for 3 months if previous cycles nl
  • absence of menses for 6 months if previous cycles irreg
  • Cause
    • THE MCC 2ary amenorrhea = PREGNANCY
    • Drug use, stress, significant weight change, or excessive exercise
    • PCOS, CNS tumor, hyperPRL, Sheehan syndrome (causes postpartum hypopit - pituitary gland is damaged, caused by excess blood loss (hemorrhage) or extremely low blood pressure during or after labor)
    • previously normal menstrual cycles and normal E, think stress or outflow obstruction (Asherman syndrome - scar tissue forms in the uterus, rare but can be a complication of multiple D&Cs)
    • If galactorrhea present, prolactinemia is MCC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amenorrhea

A
  • Primary or secondary
  • women with no menstruation in presence of E stimulation of endometrium have increased risk of endometrial cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Turner Syndrome: karyotype, PE, Labs, management

A
  • Karyotype: 45 XO
  • PE: short webbed neck, no breast development
  • Labs: High FSH
  • Management: cyclic estrogen and progestins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypothalamic-pituitary insufficiency: karyotype, PE, Labs, management

A
  • Karyotype: 46 XX
  • PE: no breast development
  • Labs: Low FSH, Low LH
  • Managment: Cyclic estrogen and progestins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Androgen insensitivity: karyotype, PE, Labs, management

A
  • karyotype: 46XY
  • PE: Normal breast development
  • Labs: High testosterone
  • Management: Remove testes; start estrogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnostic studies for amenorrhea

A
  • First line: B-hCG, TSH, PRL
  • Second line: FSH, E, LH, T
  • If bleeding occurs after progesterone challenge, anovulatory cycles are the cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Characteristics of dysfuncitonal uterine bleeding (DUB or AUB)

A
  • Presents as abnormal bleeding with a generally unremarkable PE
  • Abnormal uterine bleeding in non-pregnant women
    • different from normal cycle in terms of regularity, flow, duration, and volume
  • normally occurs right after menarche or during perimenopause
  • Causes = PALM-COIEN (polyp, adenomyosis, leiomyoma, malignancy - coag, ovulatory dysFN, endometrial, iatrogenic, not otherwise classified)
  • Menorrhagia = heavy or prolonged bleeding
  • Metrorrhagia = irregular bleeding between menses
  • PE includes speculum, evaluate for bleeding from other sources
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnostic studies for DUB

A
  • B-hCG, CBC, iron, PT, PTT, documentation of ovulation, thyroid, serum P, LFTs, PRL, serum FSH
  • Pap, US, hysterosalpingography, hysteroscopy, and/or D&C
  • endometrial bx should be done on all women over 35yo w/ obesity, HTN, or DM and on all postmenopausal pts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

management of DUB (AUB)

A
  • depends on severity of bleeding - may include observation, iron therapy, and volume replacement
  • progestin trial - if bleeding stops, anovulatory cylces are confirmed
  • OCPs:
    • older women w/o risk factors
    • OCPs should NOT be used in women over 35 who smoke, have HTN, DM, or hx of vascular dz, breast CA, liver dz, or focal HA
  • D&C can be dx and curative
  • refractory cases may require endometrial ablation or vaginal hysterectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dysmenorrhea general characteristics

A
  • PRIMARY: painful menstruation caused by increased prostaglandin and leukotriene levels - painful uterine cramping, N/V/D
    • Onset: usually w/in 2yrs menarche, peak incidence = late teens/early 20s
    • THERE IS NO PATHOLOGIC ABNORMALITY
  • SECONDARY: painful menstruation caused by identifiable condition (usually uterus or pelvis - endometriosis, adenomyosis, fibroids, PID, IUD)
    • usually affects older women (>25yo)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical features of dysmenorrhea

A
  • Primary: sxs are central lower abdomen or pelvis radiating to back or thighs, beginning before or at onset of menses, lasting 1-3 days
    • PE, labs, radiologic tests = nl
  • Secondary: similar sxs as above but may also include bloating, heavy menstrual bleeding, and dyspareunia
    • less related to first day of flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diagnostic studies for dysmenorrhea

A
  • dx of primary dysmenorrhea based on hx, use of menstrual diary, PE
  • specific tests for secondary dysmenorrhea - hysteroscopy, D&C, laparoscopy
    • all allow both dx and tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

management of dysmenorrhea

A
  • Primary:
    • start NSAIDs right before expected menses, continue 2-3 days
    • OCPs, vit B (B1, thiamine; B6, pyridoxine), magnesium, acupuncture, heat, regular exercise
  • Secondary:
    • underlying conditions should be treated
    • sx treatment may be sufficient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

general characteristics of menopause

A
  • definition: menopause is the last menses, and perimenopause (usually lasting 3-5 yrs) is the time surrounding menopause.
  • Dx made: 1 yr of no periods after age 40 with no pathologic cause
    • FSH elevated (21-100), estradiol low (<20)
    • progesterone levels nl
  • mean age = 51.5 yrs
  • smoking is associated with early menopause
  • premautre menopause (spontanous premature ovarian failure) is cessation of menses before age 40 years
  • ovaries continue to produce testosterone and androstenedione; estrone is the predominant postmenopausal circulating estrogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical features of menopause

A
  • vasomotor sxs (hot flashes) vary in intensity - usually resolve in 2-3 yrs (3-6 wks with E tx)
  • urogenital atrophy can cause poor vaginal lubrication, dyspareunia, dysuria, urge incontinence, pelvic relaxation, atrophic cystitis, easy bleeding
  • accelerated bone loss may cause osteoporosis
  • E related cardiovascular protection declines
  • changes in sleep cycle
  • skin thins, becomes less elastic, facial hair increases, hair loss increases and nails become brittle
  • confusion, memory loss, lethargy, depression, loss of sex interest
17
Q

diagnostic studies for menopause

A
  • FSH of greater than 30 is diagnostic of menopause
18
Q

management of menopause

A
  • treated on the basis of individual risk factors and sxs
  • lifestyle modifications may help sxs, reg exercise can decrease menopausal sxs
  • women with INTACT uterus should NOT use E alone (increased risk of endometrial CA)
  • combined hormone replacement tx indicated for short-term tx of hot flashes
    • can increase risk of CV dz, breast CA, and cognitive changes
  • contraindications to hormone tx include undiagnosed vaginal bleeding, acute vascular thrombosis, liver dz, hx of endometrial or breast CA
  • Ca and vit D supplementation, bisphosphonates, SERMs, calcitonin all used for osteoporosis
  • topical E can improve urogenital sxs
  • SSRI and SNRIs (caution with use with tamoxifen)
  • soy, black cohosh, and ginseng may also help alleviate sxs
19
Q

the menstrual cycle

A
  • typical cycle defined as 28 +/- 7 days
  • flow lasts 4 +/- 2 days
  • first day of bleeding = day 1 of menstrual cycle
  • luteal phase is stable, lasting 13-14 days
    • variation in cycle length generally a result of variations in the duration of the follicular phase
20
Q

ovarian function and cycle

A
  • no new ova formed after birth
  • ova undergo first meiotic division and arrest in prophase until adulthood
  • just before ovulation, first meiotic division is complete
  • secondary oocyte: begins second meiotic division and stops at metaphase - completed only when sperm penetrates
  • Mittelshmerz: ovulation pain
21
Q

premenstrual dysphoric disorder

A
  • severe PMS with functional impairment
  • PMS and PMDD are highly associated with unipolar depressive disorder and anxiety disorders, such as obsessive-compulsive disorder, panic disorder, and generalized anxiety disorder
  • type of depression that occurs during the luteal phase of the menstrual cycle
  • Criteria: 5+ sxs were present most of the cycle and during the last week of luteal phase
  • Treatment:
    • 1st line = SSRI
    • 2nd line - OCP, xanax, GnRH agonists
22
Q

PMS risk factors

A
  • FHx of PMS, vitamin B6, calcium, or magnesium deficiency
23
Q

clinical sxs of PMS

A
  • HA
  • Breast tenderness
  • Pelvic pain
  • bloating
  • premenstrual tension
  • more severe: irritability, dysphoria, mood lability
  • Abdominal discomfort, clumsiness, lack of energy, sleep changes, mood swings
  • Behavioral: social withdrawal, altered daily activities, marked change in appetite, increased crying, changes in sexual desire
24
Q

treatment of PMS

A
  • Step 1 (mild sxs): limit caffeine, alcohol, tobacco, chocolate
    • eat small frequent meals high in complex carbs
    • decrease sodium intake
    • supplements (calcium, magnesium, etc.)
    • NSAIDs
    • Bromocriptine for mastalgia
    • spironolactone for cyclic edema
    • stress management: CBT, aerobic exercise
  • Step 2 (moderate sxs): SSRIs (14d prior to the onset of menstruation and continue through the end of cycle)
    • anxiolytics: alprazolam, buspirone
  • Step 3 (severe sxs): hormonal ovulation suppression
    • OCPs
    • GnRH agonist: lupron
    • Danazol for mastalgia
    • definitive surgical tx: bilateral oophorectomy